Chandan Healthcare (NSE:CHANDAN) Net Income (Continuing Operations): ₹111 Mil (TTM As of Dec. 2025)


NSE:CHANDAN Chandan Healthcare Ltd NSE:CHANDAN
17 GF Score
Price ₹220.85
! 4 Warning Signs
View Full Analysis

What is Chandan Healthcare Net Income (Continuing Operations)?

Chandan Healthcare NSE:CHANDAN +0.57% 17 Net Income (Continuing Operations) is ₹111 Mil as of Dec. 2025. GuruFocus rates NSE:CHANDAN with a GF Score™ of 17/100. The stock has 4 warning signs investors should review.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Chandan Healthcare's Net Income (Continuing Operations) for the three months ended in Dec. 2025 was ₹50 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹111 Mil.

Chandan Healthcare  (NSE:CHANDAN) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Chandan Healthcare Net Income (Continuing Operations) Related Terms

Chandan Healthcare Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Chandan Healthcare's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandan Healthcare Net Income (Continuing Operations) Chart

Chandan Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Net Income (Continuing Operations)
-10.93 35.86 163.56 235.16

Chandan Healthcare Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Dec25
Net Income (Continuing Operations) Get a 7-Day Free Trial 0.00 46.27 60.96 0.00 50.32
NSE:CHANDAN
17GF Score
Chandan Healthcare Ltd NSE:CHANDAN
Net Income (Continuing Operations) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandan Healthcare Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹111 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of ₹111 Mil mean?
Chandan Healthcare (NSE:CHANDAN) has a Net Income (Continuing Operations) of ₹111 Mil as of Dec. 2025. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Chandan Healthcare and its competitors.
Is Chandan Healthcare's Net Income (Continuing Operations) too high?
Chandan Healthcare's current Net Income (Continuing Operations) is ₹111 Mil. Overall, Chandan Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Net Income (Continuing Operations) compare to TMO and DHR?
Chandan Healthcare's Net Income (Continuing Operations) of ₹111 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Medical Diagnostics & Research company?
A good Net Income (Continuing Operations) depends on the Medical Diagnostics & Research industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Chandan Healthcare and its competitors. Chandan Healthcare's current Net Income (Continuing Operations) is ₹111 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Net Income (Continuing Operations) of ₹111 Mil. The current Net Income (Continuing Operations) is ₹111 Mil. Chandan Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Net Income (Continuing Operations) is ₹111 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chandan Healthcare Business Description

Address Kursi Road, Biotech Park, Sector G, Jankipuram, Lucknow, UP, IND, 226021
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score

Get the complete analysis for NSE:CHANDAN

Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹220.85
Price